Venturi Wealth Management’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,629
Closed -$14.9K 629
2024
Q4
$14.9K Buy
1,629
+715
+78% +$5.26K ﹤0.01% 1335
2024
Q3
$7.11K Hold
914
﹤0.01% 1287
2024
Q2
$5.53K Hold
914
﹤0.01% 1212
2024
Q1
$5.37K Hold
914
﹤0.01% 1070
2023
Q4
$7.17K Hold
914
﹤0.01% 948
2023
Q3
$6.68K Hold
914
﹤0.01% 893
2023
Q2
$9.53K Hold
914
﹤0.01% 661
2023
Q1
$9.45K Buy
+914
New +$11.7K ﹤0.01% 723
2020
Q4
Sell
-914
Closed -$11K 306
2020
Q3
$11K Buy
+914
New +$8.68K ﹤0.01% 279

Other funds holding ANGO

Venturi Wealth Management's ANGO Position: Q1 2025 in Review

Venturi Wealth Management sold out of AngioDynamics (ANGO) in Q1 2025, closing a stake of 1,629 shares — an estimated $14.9K sold.

Venturi Wealth Management first reported a position in ANGO in Q3 2020 and held it in 9 quarters. The position peaked at $14.9K in Q4 2024. 154 funds tracked by Wall St. Rank hold ANGO as of Q1 2025.

  • Venturi Wealth Management reported no remaining AngioDynamics position as of Q1 2025 after selling out during the quarter.
  • Venturi Wealth Management sold 1,629 AngioDynamics shares in Q1 2025, an estimated $14.9K.
  • Venturi Wealth Management first reported a position in AngioDynamics in Q3 2020 and held it in 9 quarters.
  • Venturi Wealth Management's AngioDynamics position peaked at $14.9K in Q4 2024.
  • 154 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2025.

Based on Venturi Wealth Management's 13F filing for Q1 2025, filed 6 May 2025.